Ardentia Launches New Solution to Help Trusts Pseudonymise Data and Meet National Requirements

ArdentiaHealthcare business intelligence specialist Ardentia has introduced a pseudonymisation tool, designed to help NHS Trusts safely undertake secondary use of patient data and meet legal guidelines.

To meet the requirements set by the Information Commissioner's Office (ICO), all NHS Commissioners and providers of NHS commissioned care are required to complete the implementation of pseudonymisation by March 2011. Ardentia's latest solution has been developed to support Trusts during this transition, facilitating the pseudonymisation of confidential data for secondary business use.

The tool easily integrates with Ardentia's data warehouse as well as other Microsoft SQL data warehouses, meaning it can be used by a majority of Trusts to help implement the necessary changes and avoid ICO penalties.

Steve Taylor, sales & marketing manager at Ardentia said: "With all Trusts responsible for pseudonymising data not involved in the direct delivery of care by March 2011, it's vital they have in place an effective strategy to support this transition. We have developed the pseudonymisation tool to help NHS Trusts during this change, helping them to meet the legal requirements and avoid incurring penalties.

"The solution lets Trusts generate pseudonyms to remove key identifiers that may associate a treatment pathway with a particular individual, upholding patient confidentiality and meeting the requirement set out by the ICO. The software is also compatible with Microsoft SQL Server, which means Trusts can use the tool without having to purchase other Ardentia solutions."

The pseudonymisation tool allows Trusts to configure pseudonyms to be specific to an organisation, a group of users, or an individual, and ensures that only authorised personnel have access to identifiable data.

The solution operates on the Microsoft SQL Server Platform and can be integrated into Ardentia's HealthWare data warehouse as well as other Microsoft SQL Server 2008 (Enterprise edition) release 2 deployments.

About Ardentia
Ardentia is the leading dedicated supplier of healthcare solutions in the UK. We work at every level of the health service, including Trusts and PCTs among our clients, as well as SHAs and National organisations. This means that our team has unrivalled experience in delivering highly effective business information services to healthcare organisations.

Our aim is to provide those responsible for healthcare, whether they are managers or clinicians, the tools they need for evidence-based management.

That is the best way to ensure that healthcare is delivered to the highest standards of quality and as cost-effectively as possible.

www.ardentia.co.uk

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...